Published in J Clin Microbiol on February 01, 2000
DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol (2000) 4.71
Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in comparison to 16S rRNA gene sequencing for species identification of nonfermenting bacteria. J Clin Microbiol (2008) 4.18
Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol (2001) 4.02
Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis. Thorax (2004) 3.25
Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant. Infect Immun (2001) 2.76
The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients. J Bacteriol (2008) 2.71
Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex. J Clin Microbiol (2005) 2.17
Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex. J Clin Microbiol (2001) 2.06
Updated version of the Burkholderia cepacia complex experimental strain panel. J Clin Microbiol (2003) 1.74
A novel sensor kinase-response regulator hybrid controls biofilm formation and type VI secretion system activity in Burkholderia cenocepacia. Infect Immun (2008) 1.64
Species abundance and diversity of Burkholderia cepacia complex in the environment. Appl Environ Microbiol (2005) 1.62
The Burkholderia cepacia epidemic strain marker is part of a novel genomic island encoding both virulence and metabolism-associated genes in Burkholderia cenocepacia. Infect Immun (2004) 1.60
Identification of Burkholderia cenocepacia genes required for bacterial survival in vivo. Infect Immun (2004) 1.57
Development of Galleria mellonella as an alternative infection model for the Burkholderia cepacia complex. Infect Immun (2008) 1.55
Development of a recA gene-based identification approach for the entire Burkholderia genus. Appl Environ Microbiol (2005) 1.55
Diversity and evolution of the phenazine biosynthesis pathway. Appl Environ Microbiol (2009) 1.51
Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status. J Clin Microbiol (2001) 1.50
Regulation of ornibactin biosynthesis and N-acyl-L-homoserine lactone production by CepR in Burkholderia cepacia. J Bacteriol (2001) 1.49
Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomovar status and distribution of traits related to virulence and transmissibility. J Clin Microbiol (2002) 1.48
A complete lipopolysaccharide inner core oligosaccharide is required for resistance of Burkholderia cenocepacia to antimicrobial peptides and bacterial survival in vivo. J Bacteriol (2006) 1.46
Genomic diversity of Burkholderia pseudomallei clinical isolates: subtractive hybridization reveals a Burkholderia mallei-specific prophage in B. pseudomallei 1026b. J Bacteriol (2004) 1.46
Comparative analysis of plant and animal models for characterization of Burkholderia cepacia virulence. Infect Immun (2003) 1.41
Involvement of a plasmid-encoded type IV secretion system in the plant tissue watersoaking phenotype of Burkholderia cenocepacia. J Bacteriol (2004) 1.40
Diversity of cultivated endophytic bacteria from sugarcane: genetic and biochemical characterization of Burkholderia cepacia complex isolates. Appl Environ Microbiol (2007) 1.38
Macrophages, but not neutrophils, are critical for proliferation of Burkholderia cenocepacia and ensuing host-damaging inflammation. PLoS Pathog (2017) 1.38
Burkholderia thailandensis E125 harbors a temperate bacteriophage specific for Burkholderia mallei. J Bacteriol (2002) 1.36
Biofilm formation and acyl homoserine lactone production in the Burkholderia cepacia complex. J Bacteriol (2002) 1.32
Burkholderia is highly resistant to human Beta-defensin 3. Antimicrob Agents Chemother (2003) 1.29
Burkholderia pseudomallei, B. thailandensis, and B. ambifaria produce 4-hydroxy-2-alkylquinoline analogues with a methyl group at the 3 position that is required for quorum-sensing regulation. J Bacteriol (2008) 1.27
Identification of specific and universal virulence factors in Burkholderia cenocepacia strains by using multiple infection hosts. Infect Immun (2009) 1.27
A functional phenylacetic acid catabolic pathway is required for full pathogenicity of Burkholderia cenocepacia in the Caenorhabditis elegans host model. J Bacteriol (2008) 1.25
Burkholderia cenocepacia creates an intramacrophage replication niche in zebrafish embryos, followed by bacterial dissemination and establishment of systemic infection. Infect Immun (2010) 1.25
Multilocus sequence typing breathes life into a microbial metagenome. PLoS One (2006) 1.23
Distribution of quorum-sensing genes in the Burkholderia cepacia complex. Infect Immun (2001) 1.23
A decade of Burkholderia cenocepacia virulence determinant research. Infect Immun (2010) 1.22
The mgtC gene of Burkholderia cenocepacia is required for growth under magnesium limitation conditions and intracellular survival in macrophages. Infect Immun (2006) 1.22
Burkholderia cenocepacia ZmpB is a broad-specificity zinc metalloprotease involved in virulence. Infect Immun (2006) 1.22
Reconstitution of O-specific lipopolysaccharide expression in Burkholderia cenocepacia strain J2315, which is associated with transmissible infections in patients with cystic fibrosis. J Bacteriol (2005) 1.20
Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice. Infect Immun (2001) 1.19
Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar III (B. cenocepacia). J Clin Invest (2004) 1.18
Construction of aminoglycoside-sensitive Burkholderia cenocepacia strains for use in studies of intracellular bacteria with the gentamicin protection assay. Appl Environ Microbiol (2010) 1.14
Correlation between an in vitro invasion assay and a murine model of Burkholderia cepacia lung infection. Infect Immun (2002) 1.13
Quorum-sensing mutations affect attachment and stability of Burkholderia cenocepacia biofilms. Appl Environ Microbiol (2005) 1.13
Burkholderia cenocepacia C5424 produces a pigment with antioxidant properties using a homogentisate intermediate. J Bacteriol (2007) 1.13
Burkholderia spp. alter Pseudomonas aeruginosa physiology through iron sequestration. J Bacteriol (2004) 1.13
Importance of the ornibactin and pyochelin siderophore transport systems in Burkholderia cenocepacia lung infections. Infect Immun (2004) 1.11
Experimental bacteriophage therapy increases survival of Galleria mellonella larvae infected with clinically relevant strains of the Burkholderia cepacia complex. Antimicrob Agents Chemother (2009) 1.10
Identification of quorum-sensing-regulated genes of Burkholderia cepacia. J Bacteriol (2003) 1.10
Burkholderia cenocepacia requires the RpoN sigma factor for biofilm formation and intracellular trafficking within macrophages. Infect Immun (2008) 1.09
Differential mucoid exopolysaccharide production by members of the Burkholderia cepacia complex. J Clin Microbiol (2008) 1.08
Colonial morphology of Burkholderia cepacia complex genomovar III: implications in exopolysaccharide production, pilus expression, and persistence in the mouse. Infect Immun (2003) 1.08
Reciprocal regulation by the CepIR and CciIR quorum sensing systems in Burkholderia cenocepacia. BMC Genomics (2009) 1.08
A LysR-type transcriptional regulator in Burkholderia cenocepacia influences colony morphology and virulence. Infect Immun (2007) 1.07
Burkholderia cenocepacia requires a periplasmic HtrA protease for growth under thermal and osmotic stress and for survival in vivo. Infect Immun (2007) 1.07
Differential persistence among genomovars of the Burkholderia cepacia complex in a murine model of pulmonary infection. Infect Immun (2002) 1.07
Elucidating global epidemiology of Burkholderia multivorans in cases of cystic fibrosis by multilocus sequence typing. J Clin Microbiol (2007) 1.04
A Burkholderia cenocepacia orphan LuxR homolog is involved in quorum-sensing regulation. J Bacteriol (2009) 1.02
Outbreak of subclinical mastitis in a flock of dairy sheep associated with Burkholderia cepacia complex infection. J Clin Microbiol (2001) 1.01
Comparative analysis of two phenotypically-similar but genomically-distinct Burkholderia cenocepacia-specific bacteriophages. BMC Genomics (2012) 1.01
Genomovar diversity amongst Burkholderia cepacia complex isolates from an Australian adult cystic fibrosis unit. Eur J Clin Microbiol Infect Dis (2003) 1.00
Biocide susceptibility of the Burkholderia cepacia complex. J Antimicrob Chemother (2009) 1.00
Genomic analysis and relatedness of P2-like phages of the Burkholderia cepacia complex. BMC Genomics (2010) 0.99
Development of a species-specific fur gene-based method for identification of the Burkholderia cepacia complex. J Clin Microbiol (2007) 0.99
Identification of a siderophore receptor required for ferric ornibactin uptake in Burkholderia cepacia. Infect Immun (2000) 0.99
Identification of genes regulated by the cepIR quorum-sensing system in Burkholderia cenocepacia by high-throughput screening of a random promoter library. J Bacteriol (2006) 0.99
Biosynthesis and structure of the Burkholderia cenocepacia K56-2 lipopolysaccharide core oligosaccharide: truncation of the core oligosaccharide leads to increased binding and sensitivity to polymyxin B. J Biol Chem (2009) 0.98
Differential infection properties of three inducible prophages from an epidemic strain of Pseudomonas aeruginosa. BMC Microbiol (2012) 0.97
Use of suppression-subtractive hybridization to identify genes in the Burkholderia cepacia complex that are unique to Burkholderia cenocepacia. J Bacteriol (2005) 0.96
Molecular typing of, and distribution of genetic markers among, Burkholderia cepacia complex isolates from Brazil. J Clin Microbiol (2003) 0.96
Improved electrotransformation and decreased antibiotic resistance of the cystic fibrosis pathogen Burkholderia cenocepacia strain J2315. Appl Environ Microbiol (2009) 0.95
In vitro susceptibility of Burkholderia vietnamiensis to aminoglycosides. Antimicrob Agents Chemother (2011) 0.94
Characterization of SodC, a periplasmic superoxide dismutase from Burkholderia cenocepacia. Infect Immun (2007) 0.93
Direct PCR detection of Burkholderia cepacia complex and identification of its genomovars by using sputum as source of DNA. J Clin Microbiol (2002) 0.93
Developing an international Pseudomonas aeruginosa reference panel. Microbiologyopen (2013) 0.91
Inactivation of Burkholderia cepacia complex phage KS9 gp41 identifies the phage repressor and generates lytic virions. J Virol (2009) 0.91
Identification and characterization of the emhABC efflux system for polycyclic aromatic hydrocarbons in Pseudomonas fluorescens cLP6a. J Bacteriol (2003) 0.91
Burkholderia cepacia complex Phage-Antibiotic Synergy (PAS): antibiotics stimulate lytic phage activity. Appl Environ Microbiol (2014) 0.90
Bactobolin resistance is conferred by mutations in the L2 ribosomal protein. MBio (2012) 0.90
Distribution and expression of the ZmpA metalloprotease in the Burkholderia cepacia complex. J Bacteriol (2005) 0.90
Functional quorum sensing systems are maintained during chronic Burkholderia cepacia complex infections in patients with cystic fibrosis. J Infect Dis (2010) 0.90
Genomic sequence and activity of KS10, a transposable phage of the Burkholderia cepacia complex. BMC Genomics (2008) 0.89
Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex. J R Soc Med (2000) 0.88
The Burkholderia cenocepacia LysR-type transcriptional regulator ShvR influences expression of quorum-sensing, protease, type II secretion, and afc genes. J Bacteriol (2010) 0.88
Identification of potential CepR regulated genes using a cep box motif-based search of the Burkholderia cenocepacia genome. BMC Microbiol (2006) 0.88
Drosophila melanogaster as a model host for the Burkholderia cepacia complex. PLoS One (2010) 0.88
Regulation of phenylacetic acid degradation genes of Burkholderia cenocepacia K56-2. BMC Microbiol (2009) 0.88
Assessment of fluorescent in situ hybridization and PCR-based methods for rapid identification of Burkholderia cepacia complex organisms directly from sputum samples. J Clin Microbiol (2007) 0.88
Burkholderia cenocepacia ShvR-regulated genes that influence colony morphology, biofilm formation, and virulence. Infect Immun (2011) 0.88
Aerosol phage therapy efficacy in Burkholderia cepacia complex respiratory infections. Antimicrob Agents Chemother (2014) 0.86
Burkholderia cenocepacia differential gene expression during host-pathogen interactions and adaptation to the host environment. Front Cell Infect Microbiol (2011) 0.85
Key role for efflux in the preservative susceptibility and adaptive resistance of Burkholderia cepacia complex bacteria. Antimicrob Agents Chemother (2013) 0.85
Immunoproteomic analysis of proteins expressed by two related pathogens, Burkholderia multivorans and Burkholderia cenocepacia, during human infection. PLoS One (2013) 0.84
Characterization of DC1, a broad-host-range Bcep22-like podovirus. Appl Environ Microbiol (2011) 0.84
Transcriptional responses of Burkholderia cenocepacia to polymyxin B in isogenic strains with diverse polymyxin B resistance phenotypes. BMC Genomics (2011) 0.84
Identification of Burkholderia cepacia complex bacteria with a lipopolysaccharide-specific monoclonal antibody. J Med Microbiol (2010) 0.83
Genomic characterization of JG068, a novel virulent podovirus active against Burkholderia cenocepacia. BMC Genomics (2013) 0.83
Differentiation of species combined into the Burkholderia cepacia complex and related taxa on the basis of their fatty acid patterns. J Clin Microbiol (2006) 0.82
A unique regulator contributes to quorum sensing and virulence in Burkholderia cenocepacia. PLoS One (2012) 0.82
Role of lipase in Burkholderia cepacia complex (Bcc) invasion of lung epithelial cells. Eur J Clin Microbiol Infect Dis (2007) 0.82
Detection of N-acyl homoserine lactones using a traI-luxCDABE-based biosensor as a high-throughput screening tool. BMC Biotechnol (2008) 0.81
The aerobic pseudomonads: a taxonomic study. J Gen Microbiol (1966) 57.28
Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet (1993) 7.12
Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bacteriol (1997) 5.60
Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium. J Clin Microbiol (1997) 3.33
Burkholderia cepacia. Management issues and new insights. Clin Chest Med (1998) 3.23
Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting. J Clin Microbiol (1996) 2.95
Quorum sensing in Burkholderia cepacia: identification of the LuxRI homologs CepRI. J Bacteriol (1999) 2.81
Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J Clin Microbiol (1994) 2.74
Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J Clin Microbiol (1997) 2.72
Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers. J Pediatr (1988) 2.60
Multiple replicons constituting the genome of Pseudomonas cepacia 17616. J Bacteriol (1994) 2.21
Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol (1995) 2.16
Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense. J Infect Dis (1994) 2.12
Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia. Infect Immun (1996) 1.82
Siderophore production by cystic fibrosis isolates of Burkholderia cepacia. Infect Immun (1998) 1.80
Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak. Thorax (1995) 1.78
Influence of Pseudomonas aeruginosa exoproducts on virulence factor production in Burkholderia cepacia: evidence of interspecies communication. J Bacteriol (1995) 1.74
A physical genome map of the Burkholderia cepacia type strain. Mol Microbiol (1995) 1.73
Multi-resistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis. J Antimicrob Chemother (1994) 1.68
Identification of Burkholderia species and genomovars from cystic fibrosis patients by AFLP fingerprinting. Int J Syst Bacteriol (1999) 1.53
Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes. Infect Immun (1998) 1.47
Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis. J Clin Microbiol (1993) 1.45
Pseudomonas cepacia--fatal pulmonary infection in a patient with cystic fibrosis. J Infect (1986) 1.40
Insertion-sequence-dependent rearrangements of Pseudomonas cepacia plasmid pTGL1. J Bacteriol (1987) 1.33
Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium. Acta Clin Belg (1996) 1.20
Mobilization, cloning, and sequence determination of a plasmid-encoded polygalacturonase from a phytopathogenic Burkholderia (Pseudomonas) cepacia. Mol Plant Microbe Interact (1997) 1.19
Burkholderia (Pseudomonas) cepacia as a cause of brain abscesses secondary to chronic suppurative otitis media. Eur J Clin Microbiol Infect Dis (1995) 1.09
Transmission and prevalence of Burkholderia cepacia in Welsh cystic fibrosis patients. Respir Med (1998) 0.98
An outbreak of Burkholderia cepacia with septicemia on a cardiology ward. Infect Control Hosp Epidemiol (1998) 0.97
The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol (1988) 19.25
PRINTS and its automatic supplement, prePRINTS. Nucleic Acids Res (2003) 10.01
Typing of Pseudomonas pyocyanea by pyocine production. J Pathol Bacteriol (1966) 7.75
Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect Immun (1983) 6.24
Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bacteriol (1997) 5.60
Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc Natl Acad Sci U S A (1993) 4.78
DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol (2000) 4.71
Further studies in the pyocine typing of Pseudomonas pyocyanea. J Med Microbiol (1969) 4.33
Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol (1996) 4.11
Mucoid strains of Pseudomonas aeruginosa: the influence of culture medium on the stability of mucus production. J Med Microbiol (1975) 4.09
Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet (1996) 4.07
Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol (2001) 4.02
Castration of horses and analgesia. Vet Rec (2001) 4.02
Mucoid Pseudomonas aeruginosa and cystic fibrosis: resistance of the mucoid from to carbenicillin, flucloxacillin and tobramycin and the isolation of mucoid variants in vitro. J Antimicrob Chemother (1978) 3.97
Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect Immun (1994) 3.83
Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. J Clin Microbiol (1996) 3.74
Validation of 1989 Tennessee birth certificates using maternal and newborn hospital records. Am J Epidemiol (1993) 3.67
Alginate synthesis in mucoid Pseudomonas aeruginosa: a chromosomal locus involved in control. J Gen Microbiol (1980) 3.37
Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium. J Clin Microbiol (1997) 3.33
Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet (2001) 3.24
Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients. J Clin Microbiol (1999) 3.19
Respiratory viral infection and wheezy bronchitis in childhood. Thorax (1979) 3.01
Structures of herpes simplex virus type 1 genes required for replication of virus DNA. J Virol (1988) 2.97
Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting. J Clin Microbiol (1996) 2.95
Characterization of some Actinomyces-like isolates from human clinical specimens: reclassification of Actinomyces suis (Soltys and Spratling) as Actinobaculum suis comb. nov. and description of Actinobaculum schaalii sp. nov. Int J Syst Bacteriol (1997) 2.95
Mechanism of grass-pollen-induced asthma. Lancet (1992) 2.92
Acetylcholinesterase inhibition by fasciculin: crystal structure of the complex. Cell (1995) 2.80
Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J Clin Microbiol (1997) 2.72
Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia genomovar IV). J Clin Microbiol (2000) 2.63
Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database. Ann Rheum Dis (2009) 2.61
Sickness absence: facts and misconceptions. J R Coll Physicians Lond (1974) 2.57
Classification of Alcaligenes faecalis-like isolates from the environment and human clinical samples as Ralstonia gilardii sp. nov. Int J Syst Bacteriol (1999) 2.52
Can prosody aid the automatic classification of dialog acts in conversational speech? Lang Speech (2000) 2.51
Role of viruses and bacteria in acute wheezy bronchitis in childhood: a study of sputum. Arch Dis Child (1979) 2.44
Misidentification of Burkholderia cepacia in US cystic fibrosis treatment centers: an analysis of 1,051 recent sputum isolates. Chest (2000) 2.41
Power versus conventional color Doppler sonography: comparison in the depiction of vasculature in liver tumors. Radiology (1996) 2.40
Transient increase in phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol trisphosphate during activation of human neutrophils. J Biol Chem (1989) 2.35
ADSORB: a study on the efficacy of endovascular grafting in uncomplicated acute dissection of the descending aorta. Eur J Vasc Endovasc Surg (2012) 2.35
Primary structure of Torpedo californica acetylcholinesterase deduced from its cDNA sequence. Nature (1986) 2.32
Electrostatic influence on the kinetics of ligand binding to acetylcholinesterase. Distinctions between active center ligands and fasciculin. J Biol Chem (1997) 2.31
The instability of mucoid Pseudomonas aeruginosa: fluctuation test and improved stability of the mucoid form in shaken culture. J Gen Microbiol (1979) 2.31
Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates. Int J Syst Evol Microbiol (2001) 2.27
Pseudomonas cepacia in inpatients with cystic fibrosis. Lancet (1991) 2.27
Riemerella anatipestifer gen. nov., comb. nov., the causative agent of septicemia anserum exsudativa, and its phylogenetic affiliation within the Flavobacterium-Cytophaga rRNA homology group. Int J Syst Bacteriol (1993) 2.24
A numerical prognostic index for clinical use in identification of poor-risk patients with Hodgkin's disease at diagnosis. The Scotland and Newcastle Lymphoma Group (SNLG) Therapy Working Party. Leuk Lymphoma (1992) 2.23
Description of Pandoraea gen. nov. with Pandoraea apista sp. nov., Pandoraea pulmonicola sp. nov., Pandoraea pnomenusa sp. nov., Pandoraea sputorum sp. nov. and Pandoraea norimbergensis comb. nov. Int J Syst Evol Microbiol (2000) 2.20
Genetic relations between varicella-zoster virus and Epstein-Barr virus. J Gen Virol (1987) 2.17
Xanthomonas maltophilia misidentified as Pseudomonas cepacia in cultures of sputum from patients with cystic fibrosis: a diagnostic pitfall with major clinical implications. Clin Infect Dis (1995) 2.15
Revised pyocin typing method for Pseudomonas aeruginosa. J Clin Microbiol (1984) 2.15
Nonopsonic phagocytosis of strains of Pseudomonas aeruginosa from cystic fibrosis patients. Infect Immun (1984) 2.12
Right paratracheal air cysts in the thoracic inlet: clinical and radiologic significance. AJR Am J Roentgenol (1999) 2.12
Arcobacter species in humans. Emerg Infect Dis (2004) 2.11
Identification of Pandoraea species by 16S ribosomal DNA-based PCR assays. J Clin Microbiol (2001) 2.09
An inositol tetrakisphosphate-containing phospholipid in activated neutrophils. Nature (1988) 2.07
Presence of vancomycin-resistant enterococci in farm and pet animals. Antimicrob Agents Chemother (1996) 2.06
Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex. J Clin Microbiol (2001) 2.06
Relationship between reversible antagonist occupancy and the functional capacity of the acetylcholine receptor. J Biol Chem (1981) 2.05
Isolation of alginate-producing mutants of Pseudomonas fluorescens, Pseudomonas putida and Pseudomonas mendocina. J Gen Microbiol (1981) 2.04
Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia. Am J Respir Crit Care Med (2000) 2.04
Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients. J Clin Microbiol (1995) 2.04
Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans. Clin Infect Dis (2001) 2.04
Hepatitis B virus contains pre-S gene-encoded domains. Nature (1985) 2.02
The relationship between agonist occupation and the permeability response of the cholinergic receptor revealed by bound cobra alpha-toxin. J Biol Chem (1980) 2.02
Development of a multiplex PCR assay for the simultaneous detection and identification of Arcobacter butzleri, Arcobacter cryaerophilus and Arcobacter skirrowii. FEMS Microbiol Lett (2000) 2.01
Do all Pseudomonas cepacia produce carbapenemases? J Antimicrob Chemother (1993) 2.00
Restrict genetic susceptibility tests. Nature (1998) 1.99
Ralstonia taiwanensis sp. nov., isolated from root nodules of Mimosa species and sputum of a cystic fibrosis patient. Int J Syst Evol Microbiol (2001) 1.98
Classification of metal-resistant bacteria from industrial biotopes as Ralstonia campinensis sp. nov., Ralstonia metallidurans sp. nov. and Ralstonia basilensis Steinle et al. 1998 emend. Int J Syst Evol Microbiol (2001) 1.94
Functional consequences of agonist-mediated state transitions in the cholinergic receptor. Studies in cultured muscle cells. J Biol Chem (1979) 1.93
A G protein-coupled receptor for UDP-glucose. J Biol Chem (2000) 1.91
Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates. J Antimicrob Chemother (2000) 1.87
A review of the malaria situation in Zimbabwe with special reference to the period 1972-1981. Trans R Soc Trop Med Hyg (1986) 1.86
Mucoid Pseudomonas aeruginosa in cystic fibrosis: mutations in the muc loci affect transcription of the algR and algD genes in response to environmental stimuli. Mol Microbiol (1990) 1.85
Role of the far-upstream sites of the algD promoter and the algR and rpoN genes in environmental modulation of mucoidy in Pseudomonas aeruginosa. J Bacteriol (1990) 1.85
Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China. J Natl Cancer Inst (2001) 1.84
Interaction of fluorescence probes with acetylcholinesterase. The site and specificity of propidium binding. Biochemistry (1975) 1.83
Utility of commercial systems for identification of Burkholderia cepacia complex from cystic fibrosis sputum culture. J Clin Microbiol (2000) 1.82
Neonatal bone mass: influence of parental birthweight, maternal smoking, body composition, and activity during pregnancy. J Bone Miner Res (2001) 1.82
Nonopsonic phagocytosis of nonmucoid Pseudomonas aeruginosa by human neutrophils and monocyte-derived macrophages is correlated with bacterial piliation and hydrophobicity. Infect Immun (1986) 1.80
Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard? J Clin Microbiol (1995) 1.79
Common EF-hand motifs in cholinesterases and neuroligins suggest a role for Ca2+ binding in cell surface associations. Protein Sci (2000) 1.79
Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale. Neurology (2005) 1.79
Polysaccharide surface antigens expressed by nonmucoid isolates of Pseudomonas aeruginosa from cystic fibrosis patients. J Clin Microbiol (1986) 1.76
Detection of human retrovirus 5 in patients with arthritis and systemic lupus erythematosus. Arthritis Rheum (1999) 1.76